Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-23 4:30 pm Purchase | 2021-07-19 | 13G | Sera Prognostics, Inc. SERA | Vivo Capital IX LLC | 1,856,011 6.400% | 1,856,011 (New Position) | Filing History |
| 2021-04-01 4:33 pm Purchase | 2021-03-23 | 13G | Instil Bio, Inc. TIL | Vivo Capital IX LLC | 624,339 9.700% | 624,339 (New Position) | Filing History |
| 2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX LLC | 8,960,296 8.168% | -21,635,328 (-70.71%) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Vivo Capital IX LLC | 0 0.000% | -3,679,060 (Position Closed) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | Matinas BioPharma Holdings, Inc. MTNB | Vivo Capital IX LLC | 105,493 2.600% | -100,057 (-48.68%) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX LLC | 1,562,603 4.700% | 152,089 (+10.78%) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | Chinook Therapeutics, Inc. KDNY | Vivo Capital IX LLC | 987,624 2.300% | 987,624 (New Position) | Filing History |
| 2020-11-06 4:31 pm Purchase | 2020-10-29 | 13G | ESSA Pharma Inc. EPIX | Vivo Capital IX LLC | 1,410,514 4.400% | 1,410,514 (New Position) | Filing History |
| 2020-10-28 4:31 pm Purchase | 2020-10-20 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Vivo Capital IX LLC | 3,245,035 16.200% | 3,245,035 (New Position) | Filing History |
| 2020-07-29 4:35 pm Purchase | 2020-07-21 | 13G | ALX Oncology Holdings Inc. ALXO | Vivo Capital IX LLC | 4,034,522 11.100% | 4,034,522 (New Position) | Filing History |
| 2020-07-10 4:30 pm Purchase | 2020-06-30 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX LLC | 30,595,624 9.000% | 16,480,873 (+116.76%) | Filing History |
| 2020-06-30 4:30 pm Purchase | 2020-06-23 | 13G | Genetron Holdings Limited GTH | Vivo Capital IX LLC | 9,524,767 6.500% | 9,524,767 (New Position) | Filing History |
| 2020-06-26 4:31 pm Sale | 2020-06-25 | 13G | Cartesian Therapeutics, Inc. RNAC | Vivo Capital IX LLC | 45,662 1.600% | -170,085 (-78.84%) | Filing History |
| 2020-06-26 4:31 pm Purchase | 2020-06-22 | 13G | IVERIC bio, Inc. ISEE | Vivo Capital IX LLC | 4,878,048 5.800% | 4,878,048 (New Position) | Filing History |
| 2020-06-12 5:00 pm Purchase | 2020-06-04 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX LLC | 14,114,751 6.600% | 14,114,751 (New Position) | Filing History |
| 2020-06-11 5:27 pm Purchase | 2020-02-21 | 13G | ADURO BIOTECH, INC ADRO | Vivo Capital IX LLC | 4,184,776 5.200% | 4,184,776 (New Position) | Filing History |
| 2020-06-11 5:07 pm Purchase | 2020-06-01 | 13G | Larimar Therapeutics, Inc. LRMR | Vivo Capital IX LLC | 653,779 4.300% | 653,779 (New Position) | Filing History |